These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 32373971)
1. MicroRNA-9501 inhibits breast cancer proliferation and metastasis through regulating Wnt/β-catenin pathway. Que LM; Yang XR; Zhang YC; Zhong H Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4337-4347. PubMed ID: 32373971 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway. He SZ; Wang Q Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856 [TBL] [Abstract][Full Text] [Related]
3. DCLK1 promotes malignant progression of breast cancer by regulating Wnt/β-Catenin signaling pathway. Wang YL; Li Y; Ma YG; Wu WY Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9489-9498. PubMed ID: 31773701 [TBL] [Abstract][Full Text] [Related]
4. Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236. Feng F; Chen AP; Wang XL; Wu GL Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5310-5319. PubMed ID: 32495864 [TBL] [Abstract][Full Text] [Related]
5. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway. Wang FH; Ma XJ; Xu D; Luo J Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818 [TBL] [Abstract][Full Text] [Related]
6. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851 [TBL] [Abstract][Full Text] [Related]
7. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway. Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218 [TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway. Kong LY; Xue M; Zhang QC; Su CF Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression. Liu F; Liu Y; Shen J; Zhang G; Han J Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway. Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286 [TBL] [Abstract][Full Text] [Related]
11. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p. Yu XY; Tian JR; Yang D; Tan HR Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381 [TBL] [Abstract][Full Text] [Related]
12. Cathepsin C Promotes Tumorigenesis in Bladder Cancer by Activating the Wnt/β-catenin Signalling Pathway. Wang X; Jia Y; Wang D Front Biosci (Landmark Ed); 2024 Sep; 29(9):327. PubMed ID: 39344330 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway. Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949 [TBL] [Abstract][Full Text] [Related]
14. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway. Li G; Yang J; Chong T; Huang Y; Liu Y; Li H Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740 [TBL] [Abstract][Full Text] [Related]
15. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. He YM; Xiao YS; Wei L; Zhang JQ; Peng CH J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-198 inhibits metastasis of thyroid cancer by targeting H3F3A. Fang J; Zhu JM; Dai HL; He LM; Kong L Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12232-12240. PubMed ID: 33336742 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-597 inhibits NSCLC progression through negatively regulating CDK2 expression. Yu DJ; Li YH; Zhong M Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4288-4297. PubMed ID: 32373965 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-30a-3p inhibits malignant progression of hepatocellular carcinoma through regulating IGF1. Wei YY; Ren TL Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12144-12152. PubMed ID: 33336732 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/β-catenin signaling. Tian H; Wang X; Lu J; Tian W; Chen P Chem Biol Interact; 2019 Aug; 308():244-251. PubMed ID: 31145890 [TBL] [Abstract][Full Text] [Related]
20. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p. Chen AY; Zhang K; Liu GQ Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]